Neonatal jaundice secondary prevention
|
Neonatal jaundice Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neonatal jaundice secondary prevention On the Web |
|
American Roentgen Ray Society Images of Neonatal jaundice secondary prevention |
|
Risk calculators and risk factors for Neonatal jaundice secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Secondary Prevention
According to the American Academy of Pediatrics, screening for neonatal jaundice is recommended. Screening tests include the following:[1]
- Blood typing: Testing the pregnant women for the ABO blood group and Rh body autoantibodies.
- Clinical assessment: Jaundice assessment in the newborns every 8-12 hours. Assessment is performed by blanching the skin to know the color and should be done in the daylight.
- Laboratory evaluation: Measuring the level of the total serum bilirubin level in all newborns in the first day of life.
- Estimating the cause of the jaundice: Measuring the level of the G6PD enzyme.
- Risk Assessment: The newborns should be assessed for the risk of developing jaundice before discharge.
- It is recommended also for all hospitals to provide information to the parents on jaundice and its consequences.
References
- ↑ American Academy of Pediatrics Subcommittee on Hyperbilirubinemia (2004). "Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation". Pediatrics. 114 (1): 297–316. PMID 15231951.